πͺNew Research on #hsPDA & #Pharmacogenetics! π§¬
Key Insights:
β
CYP2C9*3 boosts ibuprofen response in hsPDA infants (GA>30 wks) πΆ
β
Genetic testing predicts treatment outcomes for hemodynamically significant PDA π©Ί
β
Analyzes 185 Chinese Han pediatric patients with NGS data π§ͺ
0
0
1
0